fNIRS neuroimaging in olfactory research: A systematic literature review.
aromatherapy
essential oils
fragrance
functional near-infrared spectroscopy (fNIRS)
odor
olfaction
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
09
2022
accepted:
04
11
2022
entrez:
9
1
2023
pubmed:
10
1
2023
medline:
10
1
2023
Statut:
epublish
Résumé
There are a number of key features which make olfaction difficult to study; subjective processes of odor detection, discrimination and identification, and individualistic odor hedonic perception and associated odor memories. In this systematic review we explore the role functional near-infrared spectroscopy (fNIRS) has played in understanding olfactory perception in humans. fNIRS is an optical neuroimaging technique able to measure changes in brain hemodynamics and oxygenation related to neural electrical activity. Adhering to PRISMA guidelines, results of this search found that generally the majority of studies involving healthy adult subjects observed increased activity in response to odors. Other population types were also observed, such as infants, individuals with autism, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), mild cognitive impairment (MCI) and dysosmia. fNIRS coverage heavily favored the prefrontal cortex, temporal and parietal regions. This review finds that odor induced cortical activation is dependent on multiple factors, such as odorant type, gender and population type. This review also finds that there is room for improvement in areas such as participant diversity, use of wearable fNIRS systems, physiological monitoring and multi-distance channels.
Identifiants
pubmed: 36620865
doi: 10.3389/fnbeh.2022.1040719
pmc: PMC9815777
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
1040719Informations de copyright
Copyright © 2022 Gunasekara, Gaeta, Levy, Boot and Tachtsidis.
Déclaration de conflit d'intérêts
Author GG was employed by the company Givaudan; AL and EB were employed by the company Metabolight Ltd.; IT is full time employed at University College London, is the founder of Metabolight Ltd. and a consultant to Givaudan; NG is partially funded by EPSRC and Givaudan. The authors declare that this study received funding from Givaudan. The funder only had involvement during the conception of this literature review, and the decision to publish. The funder had no involvement during data collection, analysis, interpretation or the writing of this article. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Agric Food Chem. 2012 Jan 25;60(3):805-11
pubmed: 22224859
Am J Rhinol Allergy. 2011 May-Jun;25(3):163-5
pubmed: 21679526
Psychol Sci. 2005 Sep;16(9):689-93
pubmed: 16137254
J Oleo Sci. 2017 Aug 1;66(8):843-849
pubmed: 28381767
Cereb Cortex. 2018 Sep 1;28(9):3229-3240
pubmed: 28981619
Molecules. 2020 Oct 21;25(20):
pubmed: 33096890
Alzheimers Res Ther. 2022 Mar 8;14(1):39
pubmed: 35260170
Neurosci Lett. 2008 Feb 20;432(2):157-61
pubmed: 18191897
Chem Senses. 2012 May;37(4):347-56
pubmed: 22167272
Neurophotonics. 2022 Aug;9(Suppl 2):S24001
pubmed: 36052058
Front Psychol. 2019 Feb 13;10:242
pubmed: 30814965
Neurosci Res. 2007 Nov;59(3):257-64
pubmed: 17720267
Neuropsychobiology. 2011;63(2):66-76
pubmed: 21178380
Pediatr Res. 2000 Jul;48(1):18-23
pubmed: 10879795
Psychoneuroendocrinology. 2008 Apr;33(3):328-39
pubmed: 18178322
J Laryngol Otol. 2006 Aug;120(8):638-43
pubmed: 16884548
Food Sci Nutr. 2021 Feb 16;9(4):1851-1859
pubmed: 33841804
Front Neuroanat. 2017 Apr 11;11:33
pubmed: 28443001
J Psychopharmacol. 2018 Dec;32(12):1319-1329
pubmed: 30318972
Front Neurosci. 2018 Apr 24;12:225
pubmed: 29740266
Sci Rep. 2018 Sep 13;8(1):13771
pubmed: 30213998
Arch Clin Neuropsychol. 2002 May;17(4):305-18
pubmed: 14589716
Biomed J. 2021 Dec;44(6):727-738
pubmed: 35166211
J Psychiatr Res. 2011 Nov;45(11):1463-70
pubmed: 21689828
Int J Neurosci. 2003 Jan;113(1):15-38
pubmed: 12690999
Complement Ther Med. 2014 Dec;22(6):1027-31
pubmed: 25453523
Ann N Y Acad Sci. 2020 Mar;1464(1):5-29
pubmed: 30085354
Acta Otolaryngol Suppl. 2009 Jun;(562):79-84
pubmed: 19848246
Nat Prod Commun. 2015 Jul;10(7):1305-8
pubmed: 26411036
Pediatr Res. 2001 Sep;50(3):324-30
pubmed: 11518818
Neuroimage. 2017 Jul 15;155:291-304
pubmed: 28476662
Int J Neurosci. 2005 Feb;115(2):207-22
pubmed: 15764002
Brain Sci. 2021 Jul 23;11(8):
pubmed: 34439587
Acta Paediatr. 2020 Jul;109(7):1330-1337
pubmed: 31782829
Iperception. 2022 May 22;13(3):20416695221102191
pubmed: 35646301
Chem Senses. 2014 Mar;39(3):195-202
pubmed: 24403536
PLoS One. 2013 Jun 19;8(6):e66313
pubmed: 23840440
Front Behav Neurosci. 2019 Sep 26;13:226
pubmed: 31616263
Sci Pharm. 2013 Jun;81(2):531-42
pubmed: 23833718
Gait Posture. 2012 Mar;35(3):367-72
pubmed: 22078300
J Exerc Rehabil. 2013 Apr;9(2):250-5
pubmed: 24278868
J Physiol Anthropol. 2015 Dec 22;34:44
pubmed: 26694076
J Trauma Stress. 2017 Dec;30(6):656-665
pubmed: 29160560
Brain Topogr. 2011 Jun;24(2):114-26
pubmed: 21445664
Brain Sci. 2021 May 26;11(6):
pubmed: 34073372
Acta Otolaryngol Suppl. 2004 Aug;(553):95-8
pubmed: 15277045
Early Hum Dev. 2010 Sep;86(9):541-5
pubmed: 20675084
Chem Senses. 2018 Feb 26;43(3):151-167
pubmed: 29304190
Sci Pharm. 2016 Nov 29;84(4):724-751
pubmed: 27916830
Front Hum Neurosci. 2019 Jan 21;12:533
pubmed: 30719001
Nutrients. 2021 Jan 25;13(2):
pubmed: 33503882
J Cereb Blood Flow Metab. 2004 Jun;24(6):677-80
pubmed: 15181375
Front Neurosci. 2020 Jul 09;14:724
pubmed: 32742257
Front Hum Neurosci. 2020 Oct 08;14:523456
pubmed: 33132871
Sci Rep. 2021 Jan 13;11(1):1078
pubmed: 33441798
PLoS One. 2016 Dec 9;11(12):e0168006
pubmed: 27936122
Sensors (Basel). 2021 Nov 18;21(22):
pubmed: 34833753
Sensors (Basel). 2020 Nov 19;20(22):
pubmed: 33227974